Key Developments: Instem PLC (INSC.L)

INSC.L on London Stock Exchange

162.50GBp
10:33am EDT
Price Change (% chg)

0.00p (+0.00%)
Prev Close
162.50p
Open
162.50p
Day's High
--
Day's Low
--
Volume
660
Avg. Vol
1,181
52-wk High
200.00p
52-wk Low
143.00p

Search Stocks

Latest Key Developments (Source: Significant Developments)

Instem PLC wins two contracts in Asia-Pacific
Wednesday, 16 Jul 2014 02:00am EDT 

Instem PLC:Says it has won two new contracts in Asia-Pacific region.First is five-year contract with National Shanghai Center.Says for Drug Safety Evaluation and Research (NCDSER), Chinese Contract Research Organisation (CRO), which has purchased Instem's integrated Provantis pre-clinical software suite to automate laboratory processes at their R&D facility in Shanghai, China.Contract was awarded following a detailed competitive evaluation and is of significant strategic importance as it strengthens the Company's foothold in the Asia-Pacific region.Instem's Provantis solution, which is increasingly being recognised as industry standard within China and solution around world, will replace combination of in-house developed applications and legacy systems to provide streamlined processes.It will be delivered using SaaS delivery model from Instem's Shanghai-based data center, adding another large and prestigious laboratory to Instem's established hosting data centre client roster.Second contract has been signed with an unnamed, Multi-national Corporation, which has purchased Instem's submit(tm) solution suite to support Clinical Data Interchange Standards Consortium's (CDISC) Standard for Exchange of Nonclinical Data (SEND).SEND defines organisation, structure, and format of standard non-clinical tabulation datasets for interchange between organisations such as sponsors and CROs and for submission to US Food and Drug Administration (FDA).  Full Article

Instem plc secures contract from WIL Research
Thursday, 1 May 2014 02:00am EDT 

Instem plc:Says it has been selected by WIL Research (WIL) as its exclusive non-clinical technology partner, to optimise study-related processes at all WIL worldwide sites.Says Instem to replace all existing study management systems at WIL Research.WIL Research has chosen Instem's entire Provantis software suite, including its Logbook ELN solution for paper form replacement, as part of a multi-year project.  Full Article

Instem PLC announces NIEHS extends use of Provantis Preclinical software across additional sites and users
Wednesday, 26 Mar 2014 03:01am EDT 

Instem PLC:National Institute of Environmental Health Sciences (NIEHS) has exercised year two option for Instem's Provantis preclinical software suite via SaaS (Software-as-a-Service), supporting National Toxicology Program studies.Says it has also exercised options to add two further operational sites and 100 further Provantis users.  Full Article

Instem PLC announces three year contract for animal care information system
Thursday, 20 Feb 2014 02:00am EST 

Instem PLC:Says a three year contract with a top 10 global pharmaceutical organisation for its Animal Care Information System (ACIS).The contract is worth $200,000 annually and will enhance Instem's recurring Software-as-a-Service (SaaS) revenues which already exceed $2 million per annum.  Full Article

Instem PLC Acquires Perceptive Instruments Limited
Friday, 22 Nov 2013 02:00am EST 

Instem PLC announced the acquisition of the entire issued share capital of Perceptive Instruments Limited, a company specialized in image analysis and data management solutions. The initial cash consideration of GBP 1 million will be funded from the Company's existing cash balances. The maximum consideration payable in connection with the Acquisition is GBP 1.3 million, with the GBP 0.3 million earn-out being contingent upon the performance of the acquired business in the twelve months following completion.  Full Article

Instem PLC Announces Contract For ALPHADAS Software
Tuesday, 2 Jul 2013 02:00am EDT 

Instem PLC announced a first contract win for its newly acquired ALPHADAS software. The contract consists of a high six-figure GBP perpetual licence plus implementation services, with ongoing annual support and maintenance.  Full Article

Instem PLC Acquires Logos Holdings Limited Along with its Subsidiaries Logos EDC Solutions Limited and Logos Technologies Inc
Monday, 13 May 2013 02:00am EDT 

Instem PLC announced the acquisition of the entire issued share capital of Logos Holdings Limited along with its subsidiaries Logos EDC Solutions Limited and Logos Technologies Inc, for an initial cash consideration of GBP 0.55 million. A further consideration of up to GBP 4.45 million will be payable subject to performance, in a mixture of cash and shares at the Company's discretion.  Full Article

Instem PLC Announces US Government Contract Win
Thursday, 28 Feb 2013 02:00am EST 

Instem PLC announced that the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health (NIH), has purchased the Provantis 9 preclinical software suite via SaaS (Software-as-a-Service) to support National Toxicology Program studies. These Reproductive, Immunotox, Neurobehavioural, Sensitisation and Carcinogenicity studies are primarily carried out at contractor laboratory sites throughout the United States. The value of the award to Instem, funded completely by the US government, is approximately $870,000 in the first year, with potential to extend and expand the agreement up to a further nine years, giving a possible total contract value for all 10 years of between $6.2 million-$7.6 million. The contract also includes the ability to expand to a larger number of additional sites on the same terms, which could result in further material increase in revenue.  Full Article

BlackRock UK Emerging Companies Hedge Fund Divests Stake in Instem PLC
Wednesday, 30 Jan 2013 04:42am EST 

Instem PLC announced that on January 25, 2013, BlackRock UK Emerging Companies Hedge Fund held no shares in Instem. Before the transaction of January 25, 2013, BlackRock UK Emerging Companies Hedge Fund held 401,429 shares in Instem PLC.  Full Article

JOINN Laboratories China Purchases Instem PLC's Provantis Preclinical Software Solution Suite
Thursday, 10 Jan 2013 02:01am EST 

Instem PLC announced that JOINN Laboratories (JOINN) has purchased its Provantis preclinical software solution suite to automate processes within its China-based facilities located in Beijing and Suzhou.  Full Article

Search Stocks